Categories Sites CureVac’s stock soars on GSK’s $1.56 billion deal for COVID-19 and flu vaccines – MarketWatch Post author By Mike Nova Post date July 3, 2024 CureVac’s stock soars on GSK’s $1.56 billion deal for COVID-19 and flu vaccines MarketWatch The post CureVac’s stock soars on GSK’s $1.56 billion deal for COVID-19 and flu vaccines – MarketWatch first appeared on The CoronaVirus Alerts – The News And Times. ← NPR News: 07-03-2024 8AM EDT → Florida’s COVID-19 deaths are near 3000 for 2024, up 240+ since June – Health News Florida